Data doesn’t speak for itself.

Verida Sciences, LLC, was founded by Chris Miller, PhD, a biostatistician and epidemiologist with an uncommon combination of experience in scientific communications, clinical trial design, and regulatory strategy.

We provide biostatistical and regulatory consulting with a focus on statistical communication, the work of turning data into persuasive scientific narratives that clinicians and regulators accept. We support trial design and endpoint strategy, statistical analysis plans and their execution, FDA interactions, and the documents that carry a program from development through approval. Over more than fifteen years supporting products throughout the development lifecycle, we have worked across drugs, biologics, vaccines, and devices, including rare disease and pediatric programs.

The name Verida combines veritas, the Latin word for truth, with data. Finding the truth in a clinical trial takes three things: an appropriate design to answer the question, a rigorous analysis to understand what the data show, and communication clear enough that your conclusion is persuasive to relevant stakeholders. Verida exists to do all three.